David Cella
Cella, David F., 1955-
Cella, David
VIAF ID: 23635900 (Personal)
Permalink: http://viaf.org/viaf/23635900
Preferred Forms
-
- 100 1 _ ‡a Cella, David F., ‡d 1955-
- 100 1 _ ‡a Cella, David F., ‡d 1955-
- 100 0 _ ‡a David Cella
Works
Title | Sources |
---|---|
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks | |
An item bank was created to improve the measurement of cancer-related fatigue | |
Item banking to improve, shorten and computerize self-reported fatigue: an illustration of steps to create a core item bank from the FACIT-Fatigue Scale | |
Item banks and their potential applications to health status assessment in diverse populations | |
Item response theory analyses of physical functioning items in the medical outcomes study | |
An item response theory-based pain item bank can enhance measurement precision | |
It's good to have a choice; now let's get more data: response to Armstrong et al.'s "response to Lai et al., development of a symptom index for patients with primary brain tumors". | |
Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. | |
Linking fatigue measures on a common reporting metric | |
Linking of the quality of life in neurological disorders (Neuro-QoL) to the international classification of functioning, disability and health. | |
Longitudinal and dynamic measurement invariance of the FACIT-Fatigue scale: an application of the measurement model of derivatives to ECOG-ACRIN study E2805. | |
Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis | |
Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer | |
Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. | |
Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. | |
Meaningful change in oncology quality-of-life instruments: a systematic literature review | |
Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). | |
Measuring outcomes in randomized prospective trials in palliative care | |
Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale | |
Measuring stigma across neurological conditions: the development of the stigma scale for chronic illness (SSCI) | |
Measuring the side effects of taxane therapy in oncology: the functional assesment of cancer therapy-taxane (FACT-taxane). | |
Meta-analysis provides evidence-based interpretation guidelines for the clinical significance of mean differences for the FACT-G, a cancer-specific quality of life questionnaire | |
Metaanalysis of the correlation between radiographic tumor response and patient-reported outcomes | |
Methodology for the development and calibration of the SCI-QOL item banks | |
Methods and progress in assessing the quality of life effects of supportive care with erythropoietin therapy | |
Montreal accord on patient-reported outcomes use series-paper 6: creating national initiatives to support development and use-the PROMIS example | |
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy | |
NCCN Clinical Practice Guidelines Cancer-related fatigue | |
Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease | |
New English and Spanish social health measures will facilitate evaluating health determinants | |
NUTORC-a transdisciplinary health services and outcomes research team in transplantation | |
Outcomes toolbox for head and neck cancer research | |
Overview of the Spinal Cord Injury--Quality of Life (SCI-QOL) measurement system | |
Parent-perceived child cognitive function: results from a sample drawn from the US general population | |
Parent-reported cognition of children with cancer and its potential clinical usefulness | |
Parent-reported cognitive function is associated with leukoencephalopathy in children with brain tumors | |
Patient attitudes and preferences regarding literacy screening in ambulatory cancer care clinics | |
Patient preferences in advanced or recurrent ovarian cancer | |
Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy | |
Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders | |
Patient-reported outcomes in performance measurement, 2015: | |
Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184. | |
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group | |
Patients' and Health Care Providers' Evaluation of Quality of Life Issues in Advanced Cancer Using Functional Assessment of Chronic Illness Therapy - Palliative Care Module | |
Patterns of Chronic Conditions and Their Associations With Behaviors and Quality of Life, 2010. | |
Pazopanib versus sunitinib in metastatic renal-cell carcinoma | |
Perceptions of the risks and benefits of upper limb transplantation among individuals with upper limb amputations. | |
Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial | |
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation | |
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group | |
Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study | |
Precision of health-related quality-of-life data compared with other clinical measures | |
Predicting EuroQol | |
Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors | |
Preliminary results of the generation of a shortened quality-of-life assessment for patients with advanced cancer: the FACIT-Pal-14. | |
Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors | |
Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16). | |
Progress in assessing physical function in arthritis: PROMIS short forms and computerized adaptive testing | |
PROMIS®-29 v2.0 profile physical and mental health summary scores. | |
PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions | |
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. | |
Psychological adjustment over time ... 1984 | |
A qualitative study of quality of life after stroke: the importance of social relationships | |
A randomized trial of weekly symptom telemonitoring in advanced lung cancer | |
Recent advances and continuing challenges in treating patients with lung cancer and poor performance status | |
Symptoms and quality of life in advanced non-small cell lung cancer | |
The talking touchscreen: a new approach to outcomes assessment in low literacy |